Succinylcholine Chloride Injection, Solution
NDC Package 71839-121-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Succinylcholine Chloride injection is indicated in adults and pediatric patients:as an adjunct to general anesthesiato facilitate tracheal intubationto provide skeletal muscle relaxation during surgery or mechanical ventilation. This formulation utilizes a injection, solution delivery system. Marketed by Be Pharmaceuticals Inc., this product is identified by NDC 71839-121 and is authorized under FDA application ANDA216003.

Identification & Billing

NDC Package Code
71839-121-25
Package Description
25 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE (71839-121-01)
Product Code
71839-121
11-Digit Billing Format
71839012125
RxNorm Crosswalk
RxCUI: 1594589 - succinylcholine chloride 20 MG/ML Injectable Solution

Clinical Specifications

Proprietary Name
Succinylcholine Chloride
Non-Proprietary Name
Succinylcholine Chloride
Substance Name
Succinylcholine Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
SUCCINYLCHOLINE CHLORIDE 20 mg/mL
Pharmacologic Class
Usage Information
Succinylcholine Chloride Injection is indicated in adults and pediatric patients:as an adjunct to general anesthesiato facilitate tracheal intubationto provide skeletal muscle relaxation during surgery or mechanical ventilation.

Regulatory & Marketing

Labeler Name
Be Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA216003
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-07-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71839-121-25 identifies a specific commercial package of 25 vial, multi-dose in 1 carton / 10 ml in 1 vial, multi-dose (71839-121-01) of Succinylcholine Chloride, a human prescription drug labeled by Be Pharmaceuticals Inc.. This injection, solution is formulated for intramuscular; intravenous use and contains succinylcholine chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Be Pharmaceuticals Inc. on February 07, 2022. The current certification is valid through December 31, 2026.

How is this Be Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71839012125. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71839-121-25
11-Digit CMS (5-4-2)
71839-0121-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.